• Home
  • About
    • About Panaxea
    • Meet our team
    • Careers
  • Services
    • Health Technology Assessment
    • Health Services & Systems Research
    • Health Innovation Assessment Consultancy
  • News & Cases
  • Publications
  • Contact
  • Privacy Statement Panaxea

A study into the economic impact of Integraded Care Models was published in Value of Health. The study focused on type 2 diabetes mellitus, schizophrenia, and muiltiple sclerosis. Bert Vrijhoef participated in the study as co-author, the first author of the study is Melissa Desmedt from the Faculty of Medicine and Life Sciences of the Hasselt University in Belgium.

A quote from the article:

The systematic review presented the result of cost analyses of integrated care models for type 2 diabetes mellitus, schizophrenia, and multiple sclerosis. Most of the studies reported a benificial economic impact of integrated care models. 

The full paper can be downloaded from the Value in Health website.

Panaxea b.v. supports decision making in healthcare by assessing the relative advantage of healthcare innovations. Our clients include patients, health and life science innovators and investors, health technology adopters, public and private payers, and policymakers.

Follow us on Twitter

Tweets by @PANAXEA

Useful Links

Home
About Panaxea
Services
Publications
Contact Us

Social Media

 Twitter Linkedin

Contact Information

PANAXEA b.v.
Pettelaarpark 84
5216 PP Den Bosch
The Netherlands

+31 20 7400 778
www.panaxea.eu
info@panaxea.eu

© 2019 Panaxea. All Rights Reserved.
  • Privacy Statement Panaxea
  • No translations available for this page